China Healthcare Sector Report 2020 3rd QuarterAn EMIS Insights Industry Report
EMIS is an ISI Emerging Markets Group Company Date: September 2020
Available in: English
In the second quarter 2020, China’s healthcare sector continued be challenged by the COVID-19 pandemic. As the coronavirus has been affecting the socio-economic reality in the country, in July 2020 China’s State Council released a document outlining a number of measures expected to prompt investment, improve business environment and reduce the impact of the pandemic in the country. One of the main measures stipulated in the guideline is lowering market entry barriers in some industries, including healthcare, and promotion of new business models. The major objective stressed in the guideline is to develop healthcare services, online healthcare in particular. Providers of internet-based services will be permitted to tap into the areas of diagnosis and treatment, while the internet-based services should be covered by government health insurance. In order to increase transparency in the online healthcare segment, China is expected to introduce a unified approval standard for the launch of online healthcare businesses, according to the State Council.
This report provides a complete and detailed analysis of the healthcare sector for China. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.
What this report allows you to do:
- Understand the key elements at play in the healthcare sector in China
- Access forecasts for growth in the sector
- View key data on healthcare spending and health insurance in China
- Crystallise the forces both driving and restraining this sector in China
- Build a complete perspective on sector trade, investment and employment
- Understand the competitive landscape and who the major players are
- View M&A activity and major deals
- Gain an understanding of the regulatory environment for the sector in China
- Build a clear picture of trends and issues for sub-sectors (e.g. medical institutions, medical devices and pharmaceuticals).
See below for a complete table of report contents: